In this parallel design, randomized trial, intensive treatment of systolic blood pressure (SBP) resulted in a lower incidence ...

There are three treatment groups in the ATACH trial. [132] The treatment goals are to reduce and maintain SBP for 24 hours from onset of symptoms to within the groups' target ranges: (1 ...

Stage 1 hypertension: SBP 140-159 or DBP 90-99 Stage 2 hypertension ... patient relationship and patient motivation in fostering treatment adherence. Using JNC 7 as a point of departure, an ...

Dr Ray O’Connor takes a look at the latest clinical articles on the subject of hypertension ...

Key Findings from MODERATO II The retrospective, treatment-blinded analysis assessed the impact of AVIM therapy over six months, targeting systolic blood pressure (SBP) and diastolic dysfunction ...